HEPATOID ADENOCARCINOMA OF THE STOMACH - A CLINICOPATHOLOGICAL AND IMMUNOHISTOCHEMICAL ANALYSIS

被引:13
|
作者
NAGAI, E [1 ]
UEYAMA, T [1 ]
YAO, T [1 ]
TSUNEYOSHI, M [1 ]
机构
[1] KYUSHU UNIV,SCH MED,DEPT PATHOL 2,MAIDASHI 3-1-1,HIGASHI KU,FUKUOKA 812,JAPAN
关键词
STOMACH; CARCINOMA; HEPATOID ADENOCARCINOMA; ALPHA-FETOPROTEIN; CLINICOPATHOLOGICAL AND IMMUNOHISTOCHEMICAL STUDY;
D O I
10.1002/1097-0142(19930915)72:6<1827::AID-CNCR2820720606>3.0.CO;2-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. The clinicopathologic and immunohistochemical features of the primary gastric hepatoid adenocarcinomas still remain unclear. Methods. The authors evaluated 28 hepatoid adenocarcinomas (HC) of the stomach on the basis of characteristic histologic features resembling hepatocellular carcinoma, which were selected from the 7200 cases of primary gastric carcinoma in their files. Additionally, 22 alpha-fetoprotein (AFP)-positive adenocarcinomas without hepatoid features (APC) were also selected. Results. The HC cases fell into the following two groups: HC with AFP-positive tumor cells (Group 1; 15 cases) and HC without AFP-positive cells (Group 2; 13 cases). Histologically, the glycogen granules and hyaline globules were common features in HC. The incidence of a venous invasion of HC (Groups 1 and 2) was higher than that of APC (Group 3). There were no significant differences among the three groups regarding clinical features, macroscopic features, and the incidence of lymphatic permeation. An immunohistochemical study showed that HC had differentiation into various directions. As for the advanced carcinomas, the 5-year survival rates of patients with HC (Groups 1 and 2) and those with APC (Group 3) were 11.9% (21.4%, 8.3%) and 38.2%, respectively. The prognosis of Group 1 was similar to that of Group 2, but was poorer than that of Group 3. Conclusions. The findings suggested that HC, as shown by its characteristic histologic features, had a poor prognosis whether producing AFP or not, and that HC should therefore be distinguished from AFP-positive carcinoma without hepatoid features.
引用
收藏
页码:1827 / 1835
页数:9
相关论文
共 50 条
  • [1] An analysis of clinicopathological characteristics and prognosis on hepatoid adenocarcinoma of stomach.
    Shi, Juan
    Chen, Yanping
    Liu, Lin
    Su, Xiangyu
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [2] HEPATOID ADENOCARCINOMA OF THE STOMACH - A SPECIAL CLINICOPATHOLOGICAL ENTITY
    PAUWELS, A
    AUBERTIN, JM
    DROZ, D
    DEBENES, B
    LEVY, VG
    ANNALES DE GASTROENTEROLOGIE ET D HEPATOLOGIE, 1991, 27 (03): : 135 - 136
  • [3] Clinicopathological and Prognostic Characteristics of Hepatoid Adenocarcinoma of the Stomach
    Yang, Jinlin
    Wang, Rui
    Zhang, Wenyan
    Zhuang, Wen
    Wang, Mojin
    Tang, Chengwei
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2014, 2014
  • [5] Clinicopathological and prognostic features of hepatoid adenocarcinoma of the stomach
    Zhang Jian-feng
    Shi Su-sheng
    Shao Yong-fu
    Zhang Hai-zeng
    CHINESE MEDICAL JOURNAL, 2011, 124 (10) : 1470 - 1476
  • [6] Clinicopathological features of hepatoid adenocarcinoma and non-hepatoid adenocarcinoma of the stomach: A systematic review and meta-analysis
    Ling, Qi
    Liu, Han-Lin
    Huang, Shi-Ting
    Sun, Li-Fei
    Wu, Wei-Wei
    Kudriashov, Valentin
    Liu, Kai
    Yang, Kun
    Hu, Jian-Kun
    Zhang, Wei-Han
    CANCER MEDICINE, 2024, 13 (16):
  • [7] Clinicopathological features of hepatoid adenocarcinoma of the stomach: A multicenter retrospective study
    Yanagawa, Senichiro
    Tanabe, Kazuaki
    Kano, Mikihiro
    Hotta, Ryuichi
    Saeki, Yoshihiro
    Fujikuni, Nobuaki
    Ohdan, Hideki
    CANCER REPORTS, 2024, 7 (06)
  • [8] HEPATOID ADENOCARCINOMA OF THE STOMACH
    ISHIKURA, H
    AIZAWA, M
    LABORATORY INVESTIGATION, 1987, 56 (01) : A33 - A33
  • [9] HEPATOID ADENOCARCINOMA OF THE STOMACH
    QUESNEL, T
    BOUCHET, P
    VOIRIN, L
    BLANC, M
    DARDELIN, R
    RAMOS, JM
    FAURE, H
    PRESSE MEDICALE, 1989, 18 (13): : 685 - 685
  • [10] Hepatoid adenocarcinoma of the stomach
    Inagawa S.
    Shimazaki J.
    Hori M.
    Yoshimi F.
    Adachi S.
    Kawamoto T.
    Fukao K.
    Itabashi M.
    Gastric Cancer, 2001, 4 (1) : 43 - 52